LIN28 Human

LIN28 Human Recombinant
Cat. No.
BT2825
Source
Escherichia Coli.
Synonyms
CSDD1, FLJ12457, LIN-28, LIN28A, Protein lin-28 homolog A, ZCCHC1, Zinc finger CCHC domain-containing protein 1, Lin-28A, LIN28.
Appearance
Sterile filtered colorless solution.
Purity

Greater than 85.0% as determined by SDS-PAGE

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Human LIN28 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 191 amino acids (42-209) and having a molecular mass of 21.1 kDa.
LIN28 is expressed with a 23 amino acid His tag fused at N-Terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
LIN28 is a translational enhancer that directs specific mRNAs to polysomes, enhancing protein synthesis. It serves as a marker for undifferentiated human embryonic stem cells and improves the generation of induced pluripotent stem (iPS) cells from human fibroblasts. In mouse embryonic stem cells, LIN28 binds to the let-7 pre-miRNA, inhibiting the production of mature let-7 microRNA. LIN28 overexpression is linked to human germ-cell tumors.
Description
Recombinant Human LIN28, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 191 amino acids (42-209) with a molecular weight of 21.1 kDa. It includes a 23 amino acid His tag fused at the N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
Sterile, colorless solution.
Formulation
The LIN28 protein solution (0.5 mg/ml) is formulated in 20mM Tris-HCl (pH 8), 10% glycerol, 0.1mM PMSF, and 0.1M NaCl.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity greater than 85.0% as determined by SDS-PAGE.
Synonyms
CSDD1, FLJ12457, LIN-28, LIN28A, Protein lin-28 homolog A, ZCCHC1, Zinc finger CCHC domain-containing protein 1, Lin-28A, LIN28.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSHRSMGICKWFN VRMGFGFLSM TARAGVALDP PVDVFVHQSK LHMEGFRSLK EGEAVEFTFK KSAKGLESIR VTGPGGVFCI GSERRPKGKS MQKRRSKGDR CYNCGGLDHH AKECKLPPQP KKCHFCQSIS HMVASCPLKA QQGPSAQGKP TYFREEEEEI HSPTLLPEAQ N.

Product Science Overview

Discovery and Structure

LIN28 was first identified in the nematode Caenorhabditis elegans as a heterochronic gene that affects the timing of developmental events . In humans, there are two paralogs, LIN28A and LIN28B, which share similar functions but have distinct expression patterns and regulatory mechanisms .

The protein consists of two main RNA-binding domains:

  1. N-terminal cold-shock domain (CSD): This domain is responsible for binding to RNA and is crucial for the protein’s function.
  2. C-terminal zinc-knuckle domain (ZKD): This domain also contributes to RNA binding and is essential for the specificity of LIN28’s interactions with its target RNAs .
Functions and Mechanisms

LIN28 is best known for its role in regulating the biogenesis of the let-7 family of miRNAs. It binds to the terminal loop of pri- and pre-let-7 miRNAs, preventing their processing by Drosha and Dicer, which are enzymes involved in miRNA maturation . This inhibition leads to the suppression of let-7 miRNA levels, which in turn affects the expression of various target genes involved in cell proliferation and differentiation.

In addition to its role in miRNA regulation, LIN28 also binds to and modulates the translation of specific mRNAs. This dual function allows LIN28 to coordinate complex gene expression programs that are essential for maintaining stem cell pluripotency and promoting cellular reprogramming .

Clinical Significance

Aberrant expression of LIN28 has been linked to various human diseases, including cancer. Both LIN28A and LIN28B are overexpressed in several types of tumors, such as T-cell lymphoma, neuroblastoma, breast cancer, and hepatoblastoma . The oncogenic potential of LIN28 is primarily attributed to its ability to inhibit let-7 miRNA biogenesis, leading to the upregulation of oncogenes that are normally suppressed by let-7.

Recombinant LIN28

Recombinant LIN28 proteins are produced using genetic engineering techniques, where the LIN28 gene is cloned into an expression vector and introduced into a host cell system, such as bacteria or yeast. The host cells then produce the LIN28 protein, which can be purified and used for various research applications. Recombinant LIN28 is valuable for studying the protein’s structure, function, and interactions with other molecules, as well as for developing potential therapeutic strategies targeting LIN28-related pathways.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.